INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY FILES APPLICATION FOR "T CELL RECEPTOR CHAIN-TARGETED BISPECIFIC IMMUNE EFFECTOR CELL ENGAGING ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES"

GENEVA, March 25 -- THE JOHNS HOPKINS UNIVERSITY (3400 North Charles StreetBaltimore, Maryland 21218) filed a patent application (PCT/US2025/046219) for "T CELL RECEPTOR CHAIN-TARGETED BISPECIFIC IMMUNE EFFECTOR CELL ENGAGING ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES" on Sep 12, 2025. With publication no. WO/2026/060284, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KONIG, Maximilian F. (141 N. BroadwayApt. 3Baltimore, Maryland 21231), PAUL, Suman (15 Charles PlazaApt. 801Baltimore, Maryland 21287), GLAVARIS, Stephani...